Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: A potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation

Endocrinology

Volumn 143, Issue 2, 2002, Pages 511-516

  Adi, Saleh ^a   Bin Abbas, Bassam ^a   Wu, Nan Yan ^a   Rosenthal, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOGENIN; SOMATOMEDIN A;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HORMONAL REGULATION; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0036153297     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.2.8648     Document Type: Article

References (38)

1. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts
2. Opposing early inhibitory and late stimulatory effects of insulin-like growth factor-I on myogenin gene transcription
3. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression
4. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
5. Myogenin gene disruption results in perinatal lethality because of severe muscle defect
6. Skeletal muscle determination and differentiation: Story of a core regulatory network and its context
7. Molecular and cellular aspects of the insulin-like growth factor I receptor
8. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
9. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras
10. Signaling through mitogen-activated protein kinase and Rac/ Rho does not duplicate the effects of activated Ras on skeletal myogenesis
11. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
12. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
13. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells
14. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2
15. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis
16. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis
17. Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells
18. A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide
19. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: Biological activities and receptor binding
20. S6K is differentially inhibited by LY294002 and wortmannin
21. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out
22. Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
23. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity
24. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts
25. The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: Pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor
26. Growth hormone and the insulin-like growth factor system in myogenesis
27. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts
28. Insulin-like growth factors (IGF) in muscle development
29. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation
30. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II
31. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
32. Induction and peak gene expression of insulin-like growth factor II follow that of myogenin during differentiaiton of BC3H-1 muscle cells
33. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation
34. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells
35. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells
36. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
37. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells
38. Mechanisms of insulin-like growth factor (IGF)-II-induced IGF-I receptor down-regulation in BC3H-1 muscle cells